Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care
Sign Up to like & getrecommendations! Published in 2018 at "International Psychogeriatrics"
DOI: 10.1017/s104161021800011x
Abstract: ABSTRACT Background: The use of FDA approved medications for Alzheimer's disease [AD; FDAAMAD; (cholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists)] has been associated with symptomatic benefit with a reduction in formal (paid services) and total costs… read more here.
Keywords: use fda; approved medications; informal costs; medications alzheimer ... See more keywords